Rivian's surge higher, fueled by a positive catalyst, breaking resistance, rising short interest, and positive sentiment, suggests ongoing upward momentum.
Pfizer's investment propels Caribou Biosciences' stock and fuels optimism for its lead candidates: CB-010 and CB-011, both currently in phase 1 trials.
Ford recently broke out of a wedge pattern on a higher time frame and experienced impressive follow-through momentum. The stock has risen 22% in the last month.
Shares of AMD have made a healthy retracement, and if buyers continue to step in to support the stock, a re-test of the highs could be a near-term target.
With a confirmed reversal indicated by the recent surge higher, investors may question whether it is the opportune moment to consider an investment in Wayfair.
Amid shifting fundamentals and a positive price trend, can the forgotten communication giant stage a comeback and reclaim its position in the industry?
Positive news and an unusually high short interest drove shares of CVNA higher. However, concerns surrounding the company's financials continue to cast doubt.
Dell exceeded Q1 earnings and sales expectations but faces potential significant year-over-year declines, making the situation precarious for investors.